ΔNp63α levels correlate with clinical tumor response to cisplatin

被引:78
作者
Zangen, R
Ratovitski, E
Sidransky, D
机构
[1] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Head & Neck Canc Res Div, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA
关键词
p53; p63; p73; DNA damage; cisplatin; chemotherapy; genetic marker; head and neck cancer; squamous cell carcinomas; patient outcome;
D O I
10.4161/cc.4.10.2066
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
After exposure to damaging agents, the p53 tumor suppressor is stabilized mediating cell cycle arrest and apoptosis. p53 family member, Delta Np63 promotes cell proliferation and accelerates tumor growth. We previously found that the genotoxic stress agents induced a decrease of Delta Np63 alpha. We further observed that genotoxic stress mediated phosphorylation of Delta Np63 alpha targeting it into proteasome degradation. Here, we found that high Delta Np63 protein levels in primary tumors accurately predicted response to platinum based chemotherapy and a favorable outcome in head and neck cancer patients. Our data suggest that degradation of Delta Np63 alpha is part of the cellular response to DNA damage in head and neck cancers. The findings may have implications for the rational use of DNA damaging agents in human cancer.
引用
收藏
页码:1313 / 1315
页数:3
相关论文
共 34 条
[1]   Post-translational modifications and activation of p53 by genotoxic stresses [J].
Appella, E ;
Anderson, CW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10) :2764-2772
[2]  
Brown JM, 1999, CANCER RES, V59, P1391
[3]   p63 and p73 are required for p53-dependent apoptosis in response to DNA damage [J].
Flores, ER ;
Tsai, KY ;
Crowley, D ;
Sengupta, S ;
Yang, A ;
McKeon, F ;
Jacks, T .
NATURE, 2002, 416 (6880) :560-564
[4]   RACK1 and stratifin target ΔNp63α for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage [J].
Fomenkov, A ;
Zangen, R ;
Huang, YP ;
Osada, M ;
Guo, ZM ;
Fomenkov, T ;
Trink, B ;
Sidransky, D ;
Ratovitski, EA .
CELL CYCLE, 2004, 3 (10) :1285-1295
[5]   Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck [J].
Fouret, P ;
Temam, S ;
Charlotte, F ;
Lacau-St-Guily, J .
BRITISH JOURNAL OF CANCER, 2002, 87 (12) :1390-1395
[6]   The complexity of p53 modulation: emerging patterns from divergent signals [J].
Giaccia, AJ ;
Kastan, MB .
GENES & DEVELOPMENT, 1998, 12 (19) :2973-2983
[7]  
Hagiwara K, 1999, CANCER RES, V59, P4165
[8]   AIS is an oncogene amplified in squamous cell carcinoma [J].
Hibi, K ;
Trink, B ;
Patturajan, M ;
Westra, WH ;
Caballero, OL ;
Hill, DE ;
Ratovitski, EA ;
Jen, J ;
Sidransky, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5462-5467
[9]   Apoptosis: A link between cancer genetics and chemotherapy [J].
Johnstone, RW ;
Ruefli, AA ;
Lowe, SW .
CELL, 2002, 108 (02) :153-164
[10]   Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers [J].
Kaghad, M ;
Bonnet, H ;
Yang, A ;
Creancier, L ;
Biscan, JC ;
Valent, A ;
Minty, A ;
Chalon, P ;
Lelias, JM ;
Dumont, X ;
Ferrara, P ;
McKeon, F ;
Caput, D .
CELL, 1997, 90 (04) :809-819